Cargando…
Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409034/ https://www.ncbi.nlm.nih.gov/pubmed/33764002 http://dx.doi.org/10.3324/haematol.2020.278182 |
| _version_ | 1783746914663006208 |
|---|---|
| author | Vajavaara, Heli Ekeblad, Frida Holte, Harald Jørgensen, Judit Leivonen, Suvi-Katri Berglund, Mattias Kamper, Peter Møller, Holger J. d’Amore, Francesco Molin, Daniel Enblad, Gunilla Ludvigsen, Maja Glimelius, Ingrid Leppä, Sirpa |
| author_facet | Vajavaara, Heli Ekeblad, Frida Holte, Harald Jørgensen, Judit Leivonen, Suvi-Katri Berglund, Mattias Kamper, Peter Møller, Holger J. d’Amore, Francesco Molin, Daniel Enblad, Gunilla Ludvigsen, Maja Glimelius, Ingrid Leppä, Sirpa |
| author_sort | Vajavaara, Heli |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8409034 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84090342021-09-08 Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma Vajavaara, Heli Ekeblad, Frida Holte, Harald Jørgensen, Judit Leivonen, Suvi-Katri Berglund, Mattias Kamper, Peter Møller, Holger J. d’Amore, Francesco Molin, Daniel Enblad, Gunilla Ludvigsen, Maja Glimelius, Ingrid Leppä, Sirpa Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-03-25 /pmc/articles/PMC8409034/ /pubmed/33764002 http://dx.doi.org/10.3324/haematol.2020.278182 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Vajavaara, Heli Ekeblad, Frida Holte, Harald Jørgensen, Judit Leivonen, Suvi-Katri Berglund, Mattias Kamper, Peter Møller, Holger J. d’Amore, Francesco Molin, Daniel Enblad, Gunilla Ludvigsen, Maja Glimelius, Ingrid Leppä, Sirpa Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma |
| title | Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma |
| title_full | Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma |
| title_fullStr | Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma |
| title_full_unstemmed | Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma |
| title_short | Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma |
| title_sort | prognostic impact of soluble cd163 in patients with diffuse large b-cell lymphoma |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409034/ https://www.ncbi.nlm.nih.gov/pubmed/33764002 http://dx.doi.org/10.3324/haematol.2020.278182 |
| work_keys_str_mv | AT vajavaaraheli prognosticimpactofsolublecd163inpatientswithdiffuselargebcelllymphoma AT ekebladfrida prognosticimpactofsolublecd163inpatientswithdiffuselargebcelllymphoma AT holteharald prognosticimpactofsolublecd163inpatientswithdiffuselargebcelllymphoma AT jørgensenjudit prognosticimpactofsolublecd163inpatientswithdiffuselargebcelllymphoma AT leivonensuvikatri prognosticimpactofsolublecd163inpatientswithdiffuselargebcelllymphoma AT berglundmattias prognosticimpactofsolublecd163inpatientswithdiffuselargebcelllymphoma AT kamperpeter prognosticimpactofsolublecd163inpatientswithdiffuselargebcelllymphoma AT møllerholgerj prognosticimpactofsolublecd163inpatientswithdiffuselargebcelllymphoma AT damorefrancesco prognosticimpactofsolublecd163inpatientswithdiffuselargebcelllymphoma AT molindaniel prognosticimpactofsolublecd163inpatientswithdiffuselargebcelllymphoma AT enbladgunilla prognosticimpactofsolublecd163inpatientswithdiffuselargebcelllymphoma AT ludvigsenmaja prognosticimpactofsolublecd163inpatientswithdiffuselargebcelllymphoma AT glimeliusingrid prognosticimpactofsolublecd163inpatientswithdiffuselargebcelllymphoma AT leppasirpa prognosticimpactofsolublecd163inpatientswithdiffuselargebcelllymphoma |